{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:53:24Z","timestamp":1781654004798,"version":"3.54.5"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Beijing Municipal Clinical Key Specialty Construction Program"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to characterize the clinical features, maternal-fetal outcomes, and prognostic factors of pregnant patients with first-onset acute leukemia (AL) at a specialized referral center in China.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective descriptive study was conducted on 53 pregnant patients diagnosed with de novo AL and treated at Peking University People\u2019s Hospital between January 2010 and January 2024. Clinical data, including maternal baseline characteristics, treatment protocols, pregnancy outcomes, and long-term maternal\/neonatal follow-up results, were collected and analyzed. Survival outcomes were estimated using Kaplan-Meier curves, and prognostic factors for maternal mortality were identified via Cox regression analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of the 53 patients, 40 (75.5%) had acute myeloid leukemia (AML) and 13 (24.5%) had acute lymphoblastic leukemia (ALL); AL onset occurred in the first (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200912, 22.6%), second (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200928, 52.8%), and third (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200913, 24.6%) trimesters. The most common initial symptoms were oral manifestations (34.0%, e.g., gingival bleeding\/hyperplasia), while thrombocytopenia (94.3%) and anemia (86.8%) were the most prevalent peripheral blood abnormalities. 23 (43.4%) patients reached the peripartum period (\u2265\u200928 weeks), with 56.5% preterm births and 13.0% fetal growth restriction (FGR). Gestational age at AL onset was the only factor significantly associated with peripartum progression (OR\u2009=\u20091.642,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Seven patients received antenatal induction chemotherapy, all achieving live births. Long-term follow-up (median: 4.4 years) of 17\/22 live-born children showed no growth restriction or neurodevelopmental delays. The 5-year overall survival (OS) and disease-free survival (DFS) rates for mothers were 50.9% and 41.5%, respectively. Cox regression identified disseminated intravascular coagulation (DIC, HR\u2009=\u20095.274,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.022) and leukocytosis (HR\u2009=\u20095.009,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.025) as independent risk factors for maternal mortality; chemotherapy delay (&gt;\u200930 days) was associated with lower complete remission (CR) rates (66.7% vs. 87.1%) and higher mortality (50% vs. 26.7%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Unexplained thrombocytopenia or oral manifestations are key early indicators for targeted AL screening in pregnant patients. Gestational age at AL onset was the only factor significantly associated with peripartum progression. Disseminated intravascular coagulation and leukocytosis were independent risk factors for maternal mortality. Among 17 live-born children with a median follow-up of 4.4 years, no growth restriction or neurodevelopmental delays were observed, including 6 infants exposed to antenatal ATRA-based chemotherapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12884-026-08737-7","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T07:53:08Z","timestamp":1770191588000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical features and maternal-fetal outcomes of patients with first-onset acute leukemia during pregnancy: a retrospective study from pregnancy hematological disease referral center"],"prefix":"10.1186","volume":"26","author":[{"given":"Xue","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-ying","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-min","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-long","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,4]]},"reference":[{"issue":"1","key":"8737_CR1","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1186\/s12885-017-3436-9","volume":"17","author":"NS Fracchiolla","year":"2017","unstructured":"Fracchiolla NS, Scium\u00e8 M, Dambrosi F, et al. Acute myeloid leukemia and pregnancy: clinical experience from a single center and a review of the literature. BMC Cancer. 2017;17(1):442.","journal-title":"BMC Cancer"},{"issue":"20","key":"8737_CR2","doi-asserted-by":"publisher","first-page":"3514","DOI":"10.1080\/14767058.2019.1579188","volume":"33","author":"S Nolan","year":"2020","unstructured":"Nolan S, Czuzoj-Shulman N, Abenhaim HA. Obstetrical and newborn outcomes among women with acute leukemias in pregnancy: a population-based study. J Matern Fetal Neonatal Med. 2020;33(20):3514\u201320.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"2","key":"8737_CR3","doi-asserted-by":"publisher","first-page":"e151","DOI":"10.1016\/S2352-3026(24)00309-0","volume":"12","author":"G Mills","year":"2025","unstructured":"Mills G, Shand A, Kennedy D, et al. Position statement on the diagnosis and management of acute leukaemia and aggressive lymphomas in pregnancy. Lancet Haematol. 2025;12(2):e151\u201362.","journal-title":"Lancet Haematol"},{"issue":"13","key":"8737_CR4","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1111\/j.1471-0528.2012.03475.x","volume":"119","author":"YY Lee","year":"2012","unstructured":"Lee YY, Roberts CL, Dobbins T, et al. Incidence and outcomes of pregnancy-associated cancer in Australia, 1994\u20132008: a population-based linkage study. BJOG. 2012;119(13):1572\u201382.","journal-title":"BJOG"},{"issue":"1","key":"8737_CR5","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12884-023-05359-1","volume":"23","author":"N Safi","year":"2023","unstructured":"Safi N, Li Z, Anazodo A, et al. Pregnancy associated cancer, timing of birth and clinical decision making-a NSW data linkage study. BMC Pregnancy Childbirth. 2023;23(1):105.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"9815","key":"8737_CR6","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/S0140-6736(11)61348-2","volume":"379","author":"B Brenner","year":"2012","unstructured":"Brenner B, Avivi I, Lishner M. Haematological cancers in pregnancy. Lancet. 2012;379(9815):580\u20137.","journal-title":"Lancet"},{"issue":"9","key":"8737_CR7","doi-asserted-by":"publisher","first-page":"e705","DOI":"10.1016\/S2352-3026(23)00238-7","volume":"10","author":"R Birsen","year":"2023","unstructured":"Birsen R, Pinson P, Chouchana L, Boussaid I, Treluyer JM. Haematological malignancies in pregnancy: time for accurate incidence data. Lancet Haematol. 2023;10(9):e705.","journal-title":"Lancet Haematol"},{"issue":"5","key":"8737_CR8","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.3390\/jcm14051399","volume":"14","author":"A Vuong","year":"2025","unstructured":"Vuong A, Tran NH, Pham TH, Le H, Nguyen PN. Soluble fibrin monomer complex and D-Dimer concentrations between patients at low and high risk of venous thromboembolism before delivery according to RCOG score assessment: an observational study among 100 Third-Trimester Vietnamese pregnancies. J Clin Med. 2025;14(5):1399.","journal-title":"J Clin Med"},{"issue":"4","key":"8737_CR9","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1111\/bjh.13554","volume":"170","author":"S Ali","year":"2015","unstructured":"Ali S, Jones GL, Culligan DJ, et al. Guidelines for the diagnosis and management of acute myeloid leukaemia in pregnancy. Br J Haematol. 2015;170(4):487\u201395.","journal-title":"Br J Haematol"},{"issue":"20","key":"8737_CR10","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the world health organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391\u2013405.","journal-title":"Blood"},{"issue":"5","key":"8737_CR11","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1080\/01443615.2016.1268575","volume":"37","author":"M Sanci","year":"2017","unstructured":"Sanci M, T\u00f6z E, Ince O, et al. Reference values for maternal total and differential leukocyte counts in different trimesters of pregnancy and the initial postpartum period in Western Turkey. J Obstet Gynaecol. 2017;37(5):571\u20135.","journal-title":"J Obstet Gynaecol"},{"issue":"4","key":"8737_CR12","first-page":"281","volume":"47","author":"Capital Institute of Pediatrics, Coordinating Study Group of Nine Cities on the Physical Growth and Development of Children","year":"2009","unstructured":"Capital Institute of Pediatrics, Coordinating Study Group of Nine Cities on the Physical Growth and Development of Children. [Growth standardized values and curves based on weight for length\/height, body mass index for Chinese children under 7 years of age]. Zhonghua Er Ke Za Zhi. 2009;47(4):281\u20135.","journal-title":"Zhonghua Er Ke Za Zhi"},{"issue":"12","key":"8737_CR13","first-page":"913","volume":"53","author":"M Wei","year":"2015","unstructured":"Wei M, Bian X, Squires J, et al. [Studies of the norm and psychometrical properties of the ages and stages questionnaires, third edition, with a Chinese National sample]. Zhonghua Er Ke Za Zhi. 2015;53(12):913\u20138.","journal-title":"Zhonghua Er Ke Za Zhi"},{"issue":"2","key":"8737_CR14","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/imhj.21626","volume":"38","author":"X Bian","year":"2017","unstructured":"Bian X, Xie H, Squires J, Chen CY, ADAPTING A PARENT-COMPLETED. SOCIOEMOTIONAL QUESTIONNAIRE IN CHINA: THE AGES & STAGES QUESTIONNAIRES: SOCIAL-EMOTIONAL. Infant Ment Health J. 2017;38(2):258\u201366.","journal-title":"Infant Ment Health J"},{"issue":"3","key":"8737_CR15","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S1470-2045(18)30059-7","volume":"19","author":"J de Haan","year":"2018","unstructured":"de Haan J, Verheecke M, Van Calsteren K, et al. Oncological management and obstetric and neonatal outcomes for women diagnosed with cancer during pregnancy: a 20-year international cohort study of 1170 patients. Lancet Oncol. 2018;19(3):337\u201346.","journal-title":"Lancet Oncol"},{"issue":"1","key":"8737_CR16","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12245-024-00587-4","volume":"17","author":"A Vuong","year":"2024","unstructured":"Vuong A, Pham TH, Bui VH, et al. Successfully Conservative management of the uterus in acute pulmonary embolism during Cesarean section for placenta previa: a case report from Tu du Hospital, Vietnam and literature review. Int J Emerg Med. 2024;17(1):14.","journal-title":"Int J Emerg Med"},{"issue":"11","key":"8737_CR17","doi-asserted-by":"publisher","first-page":"e850","DOI":"10.1016\/S2352-3026(24)00288-6","volume":"11","author":"P Pinson","year":"2024","unstructured":"Pinson P, Boussaid I, Decroocq J, et al. Maternal and obstetric outcomes in women with pregnancy-associated haematological malignancies: an observational nationwide cohort study. Lancet Haematol. 2024;11(11):e850\u201361.","journal-title":"Lancet Haematol"},{"issue":"1","key":"8737_CR18","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1080\/07853890.2021.1908586","volume":"53","author":"D Zhu","year":"2021","unstructured":"Zhu D, Tang D, Chai X, Zhang G, Wang Y. Acute leukemia in pregnancy: a single institutional experience with 21 cases at 10 years and a review of the literature. Ann Med. 2021;53(1):567\u201375.","journal-title":"Ann Med"},{"issue":"4","key":"8737_CR19","doi-asserted-by":"publisher","first-page":"719","DOI":"10.3324\/haematol.2016.158394","volume":"102","author":"AT Fathi","year":"2017","unstructured":"Fathi AT, Wander SA, Blonquist TM, et al. Phase I study of the Aurora A kinase inhibitor Alisertib with induction chemotherapy in patients with acute myeloid leukemia. Haematologica. 2017;102(4):719\u201327.","journal-title":"Haematologica"},{"key":"8737_CR20","doi-asserted-by":"publisher","first-page":"803994","DOI":"10.3389\/fonc.2021.803994","volume":"11","author":"P Wang","year":"2021","unstructured":"Wang P, Yang Z, Shan M, et al. Maternal and fetal outcomes of acute leukemia in pregnancy: A retrospective study of 52 patients. Front Oncol. 2021;11:803994.","journal-title":"Front Oncol"},{"issue":"24","key":"8737_CR21","doi-asserted-by":"publisher","first-page":"4213","DOI":"10.1002\/cncr.34495","volume":"128","author":"F Pastore","year":"2022","unstructured":"Pastore F, Pastore A, Rothenberg-Thurley M, et al. Molecular profiling of patients with cytogenetically normal acute myeloid leukemia and hyperleukocytosis. Cancer. 2022;128(24):4213\u201322.","journal-title":"Cancer"},{"issue":"3","key":"8737_CR22","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3816\/CLM.2001.n.023","volume":"2","author":"A Avil\u00e9s","year":"2001","unstructured":"Avil\u00e9s A, Neri N. Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero. Clin Lymphoma. 2001;2(3):173\u20137.","journal-title":"Clin Lymphoma"},{"issue":"9","key":"8737_CR23","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/S1470-2045(12)70331-5","volume":"13","author":"O Mir","year":"2012","unstructured":"Mir O, Berveiller P. Increased evidence for use of chemotherapy in pregnancy. Lancet Oncol. 2012;13(9):852\u20134.","journal-title":"Lancet Oncol"},{"issue":"1","key":"8737_CR24","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1093\/annonc\/mdh009","volume":"15","author":"N Germann","year":"2004","unstructured":"Germann N, Goffinet F, Goldwasser F. Anthracyclines during pregnancy: embryo-fetal outcome in 160 patients. Ann Oncol. 2004;15(1):146\u201350.","journal-title":"Ann Oncol"},{"issue":"3","key":"8737_CR25","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1093\/jnci\/djae273","volume":"117","author":"A Metcalfe","year":"2025","unstructured":"Metcalfe A, Cairncross ZF, McMorris CA, et al. Cancer chemotherapy in pregnancy and adverse pediatric outcomes: a population-based cohort study. J Natl Cancer Inst. 2025;117(3):554\u201361.","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"8737_CR26","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/S2352-4642(17)30091-3","volume":"1","author":"T Vandenbroucke","year":"2017","unstructured":"Vandenbroucke T, Verheecke M, Fumagalli M, Lok C, Amant F. Effects of cancer treatment during pregnancy on fetal and child development. Lancet Child Adolesc Health. 2017;1(4):302\u201310.","journal-title":"Lancet Child Adolesc Health"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-026-08737-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-026-08737-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-026-08737-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:04:22Z","timestamp":1781651062000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12884-026-08737-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,4]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8737"],"URL":"https:\/\/doi.org\/10.1186\/s12884-026-08737-7","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,4]]},"assertion":[{"value":"4 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Peking University People\u2019s Hospital. Given its retrospective design, a waiver of informed consent was granted by the ethics committee. All procedures involving human participants and human data were conducted in full compliance with the ethical principles outlined in the World Medical Association Declaration of Helsinki. Patient privacy and the confidentiality of personal health information were strictly protected throughout the study process, in accordance with the Declaration\u2019s requirements for the protection of research participants\u2019 rights and interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participants have provided written consent for the publication of any potentially identifiable data and information related to this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"233"}}